Jump to content
  • Want to be a part of a supportive community? Join the H Opp community for free.

    Welcome to the Herpes Opportunity Support Forum! We are a supportive and positive group to help you discover and live your Opportunity. Together, we can shed the shame and embrace vulnerability and true connection. Because who you are is more important than what you have. Get your free e-book and handouts here: https://www.herpesopportunity.com/lp/ebook

New shingles vaccine xtraordinarily effective


Recommended Posts

https://finance.yahoo.com/news/positive-outcome-phase-3-study-120000999.html

 

New shingles vaccine 97% effective in preventing shingles as shown in a large phase 3 study.

What's so unique is this is the first subunit vaccine that has been successful, after dozens of failed subunits (including several for HSV). Also contrary to historical vaccine development, this vaccine is vastly superior to its live virus vaccine counterpart, which is only 50% effective in preventing shingles. After numerous failed subunit HSV vaccines, there was growing concern that the only path to a successful HSV vaccine would be the live virus route (of which there are none in clinical trials- all of the current HSV vaccine ex in clinical trials are subunit except ACAM 529, which is a dead virus vaccine). This shingles vaccine proves that a subunit HSV vaccine may indeed be possible, especially considering HSV and shingles are closely related. The founding company, Agenus, has a HSV vaccine in clinical trials now that uses the same adjuvant and is based on the same premise as its shingles vaccine. This is great news for all of us here.

Link to comment

Well, lets hope so ... but as someone who has seen a lot of trials/etc shut down by the FDA in my 35 yrs with H, I'll believe it when I see it out there ...

 

I DO believe that we will get something in the next 5-10 yrs ... simply as a by-product of Shingles and HIV studies ... much of how they come up with vaccines there will transfer to finding one for HSV ..... which reduces the time and expense of coming up with something that many of them consider a non-life-threatening (and thus less urgent) issue.

 

Also, the first vaccines usually are not the "best" in the long run (just as with the Shingles vaccines ... ) ... so we have a bit of a way to go before we get a true cure ... but the really, really GOOD news is that there seems to be a number of smaller drug companies who are trying to break into the market who are working on coming up with something that will work. Until relatively recently Big Pharma controlled most of the trials ... competition to break into the field will be very advantageous for us in the long run :)

 

Just want to remind you to remember to live your live TODAY .... don't hold out on love waiting for a vaccine ... because if *I* had, I'd never have met the 3 lovely men who have graced my life ... and even tho they didn't work out, they brought a lot of good things to me and I learned a lot about myself with them.....so don't deny yourself of love if it comes your way :)

 

(((HUGS)))

Link to comment

@getbetter

 

Genocea's vaccine is meant to be therapeutic, not preventative, and the preliminary data is not encouraging (42% reduction in outbreaks at 6 months post-injection, return to baseline 12 months post-injection). This would make Gen 003 less efficacious than Valtrex. Genocea is running another trial with altered dosing and adjuvant, and this data will be available next year. They will also be recording shedding rates during this trial.

 

Sanofi-Pasteur, Agenus, and Admedus are all working on prophylactic (preventative) vaccines. Personally I would much rather a preventative vaccine be found. This will do infinitely more to reduce stigma and mitigate risk than any therapeutic vaccine ever could.

Link to comment

therapeutic would be nice but a bigger market is in preventative and if you really think about it would help with those of us who have H. meet someone, grow to like them, disclose; either they have had the shot OR they go get the shot and no worries.

 

I know it doesn't help those of us with H but imagine a world where it wouldn't matter.

 

of course the moment a preventative comes along all research stops on therapeutic as it would be a dwindling consumer base over time.

Link to comment

I just happened to see this today while doing some winter cleaning and thought this would be a good thread to throw it in on. :)

 

For anyone interested in knowing the drug testing process from development to approval, I found this graphic in some of my paperwork that shows the phases and timelines:

http://screencast.com/t/O5TidyhLE

Notes:

  • My mother is now in hospice with end-stage cancer, so I am at her house a lot these days helping where I can until she passes. Thank you in advance for understanding if I am not as quick to respond as I normally would be. This is a precious and bittersweet time …
  • This content is for informational purposes only. This information does not constitute medical advice or diagnosis. I'm not a medical professional, so please take this as friendly peer support. 

Helpful resources:

Link to comment

so the one we are discussing was 1.5 years away because it was in ph3? and all because some monkeys got skin conditions at 900x the dosage? why the hell would monkeys want to take it anyway?

 

@ john, yea I had read up on that one. if I remember it was either 1 400 mg pill a week or 1 75 a day and almost no shedding and nearly no OBs.

Link to comment

@john

 

No there are no updates from the FDA standpoint. In all likelihood the hold will not lifted. There is a rumor that the developing company, in a last ditch effort to get the drug approved, will apply for orphan drug status to treat people with acyclovir-resistant strains of HSV. Unfortunately this means the drug will not be available to most of us, unless you can convince a doctor to prescribe the medication off label. And even then, insurance will not cover off label meds, so it will be ridiculously expensive.

 

On the bright side, a similar drug, ASP 2151, with the same mechanism of action (helicase inhibitor) as pritelivir, is in stage 3 trials in Japan. Even if approved in Japan, if/when it is approved here is anyone's guess. The chickenpox vaccine we know give our children was approved in Japan 17 years prior to being approved here.

Link to comment

@ white daisies

 

http://depts.washington.edu/hivaids/derm/case2/discussion.html

 

"The first goal is to establish the diagnosis of HSV. If acyclovir resistance is suspected, testing for HSV should include a viral culture of the sample, since resistance testing will require isolation of virus. Laboratory testing for acyclovir resistance includes a variety of phenotypic assays, such as the plaque-reduction assay, dye-uptake assays, and viral DNA-inhibition assays[5]. Among these assays, the plaque reduction assay is the most frequently used and resistance is characteristically defined as an IC50 greater than 2 ug/ml[5], with non-resistant isolates typically having an IC50 of approximately 0.1 ug/ml[3,12]. Within a single lesion, heterogeneous virus populations may exist composed of susceptible and resistant strains."

 

You may have to contact UW to find out where to actually go if you are interested in acyclovir resistance testing.

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...